Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long‐term study
Abstract Background Pulmonary arterial hypertension (PAH) is a progressive disease with limited survival. Iron deficiency (ID) correlates with disease severity and mortality. While oral iron supplementation was shown to be insufficient in such patients, the potential impact of parenteral iron on cli...
Saved in:
Main Authors: | Tilmann Kramer (Author), Max Wissmüller (Author), Kristiana Natsina (Author), Felix Gerhardt (Author), Henrik tenFreyhaus (Author), Daniel Dumitrescu (Author), Thomas Viethen (Author), Martin Hellmich (Author), Stephan Baldus (Author), Stephan Rosenkranz (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ferric Carboxymaltose in the Treatment of Iron-Deficiency Anaemia in Paediatric Patients with Anastomotic Ulcers
by: Chiara Udina, et al.
Published: (2022) -
Iron deficiency anemia with menorrhagia: Ferric carboxymaltose a safer alternative to blood transfusion
by: Vineet Mishra, et al.
Published: (2018) -
Assessing the costs and benefits of perioperative iron deficiency anemia management with ferric carboxymaltose in Germany
by: Froessler B, et al.
Published: (2018) -
Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial
by: Ambily Jose, et al.
Published: (2019) -
Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials
by: Amreen Naqash, et al.
Published: (2018)